Sign In
Buy CLRB
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
Observers: Forces Behind U.S. Riots Fueled 2019 Latin America Violence
10:00am, Friday, 05'th Jun 2020
Protests in the U.S. attracted Latin American leftist iconography this week – not a coincidence, observers told Breitbart News.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs June 3)
Arena Pharmaceuticals, Inc. (...
Nod to amend Essential Commodities Act, empowered panel to woo investors: Watch cabinet briefing highlights
02:33pm, Wednesday, 03'rd Jun 2020
The Union Cabinet Wednesday approved amendment to the six-a-and-half decade old Essential Commodities Act to deregulate food items, including cereals, pulses and onion, a move that will transform the
Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering At $1.15 Per Share
01:02pm, Wednesday, 03'rd Jun 2020Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering
01:00pm, Wednesday, 03'rd Jun 2020
Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pr
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.05%
12:00am, Wednesday, 03'rd Jun 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.05%
When rugby, football and all the other professional sports are returning
12:54pm, Monday, 01'st Jun 2020
Here's the latest information on when professional sports are set to resume and what events will take place
Continental Resources: Navigating Through The Downturn (NYSE:CLR)
12:07pm, Monday, 01'st Jun 2020
Continental Resources might report a double-digit drop in output for Q2-2020, which, combined with weak oil prices, will push its earnings and cash flows lower.
Cellectar Granted SME Status by the European Medicines Agency
12:00pm, Monday, 01'st Jun 2020
Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that i
How Boots has been operating and supporting people during pandemic
11:33am, Monday, 01'st Jun 2020
Nottinghamshire's biggest company has been at the forefront
